Strata Critical Medical Raises FY2026 Sales Guidance from $260.000M-$275.000M to $285.000M-$295.000M vs $275.746M Est
Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $260.000 million-$275.000 million to $285.000 million-$295.000 million vs $275.746 million estimate.
Strata Critical Medical says it will make more money next year than it thought before—between $285 and $295 million instead of $260 to $275 million. When a company raises its own forecast, it usually means things are going better than expected, so watch to see if they keep delivering on this bigger promise.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.